| CTRI Number |
CTRI/2025/08/092846 [Registered on: 11/08/2025] Trial Registered Prospectively |
| Last Modified On: |
11/08/2025 |
| Post Graduate Thesis |
Yes |
| Type of Trial |
Interventional |
|
Type of Study
|
Homeopathy |
| Study Design |
Single Arm Study |
|
Public Title of Study
|
A study to find out how well homoeopathy helps people with asthma and other related health problems |
|
Scientific Title of Study
|
Effectiveness of Individualized Homoeopathic Medicine in the Management of Bronchial Asthma and it’s Co morbidities – A Prospective Clinical Study. |
| Trial Acronym |
Nil |
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NIL |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Dr KEERTHANA K |
| Designation |
Junior Resident |
| Affiliation |
Sarada krishna homoeopathic medical college,kulasekharam. |
| Address |
Room no 403,3rd floor ,college building , department of organon of medicine and homoeopathic philosophy,sarada krishna homoeopathic medical college,kulasekharam.
Kanniyakumari
TAMIL NADU
629161
India |
| Phone |
7358779930 |
| Fax |
|
| Email |
drkeerthu01@gmail.com |
|
Details of Contact Person
Scientific Query
|
| Name |
Dr MURUGAN M |
| Designation |
Professor and Head of the department |
| Affiliation |
Sarada krishna homoeopathic medical college,kulasekharam. |
| Address |
Room no 403,3rd floor,college building,department of organon of medicine and homoeopathic philosophy,sarada krishna homoeopathic medical college,kulasekharam.
Kanniyakumari
TAMIL NADU
629161
India |
| Phone |
9443343707 |
| Fax |
|
| Email |
drmmuruganhomoeo@gmail.com |
|
Details of Contact Person
Public Query
|
| Name |
Dr MURUGAN M |
| Designation |
Professor and Head of the department |
| Affiliation |
sarada krishna homoeopathic medical college,kulasekharam |
| Address |
Room no 403,3rd floor,college building,department of organon of medicine and homoeopathic philosophy,sarada krishna homoeopathic medical college,kulasekharam.
Kanniyakumari
TAMIL NADU
629161
India |
| Phone |
9443343707 |
| Fax |
|
| Email |
drmmuruganhomoeo@gmail.com |
|
|
Source of Monetary or Material Support
|
| INSTITUTION - Sarada Krishna Homoeopathic Medical College, Kulasekharam,Kanniyakumari district,Tamil Nadu,India 629161 |
|
|
Primary Sponsor
|
| Name |
Psot Graduate Research funded by college |
| Address |
Sarada Krishna Homoeopathic Medical College, Kulasekharam,Kanniyakumari district,Tamil Nadu,India 629161 |
| Type of Sponsor |
Private medical college |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| Dr KEERTHANA K |
Sarada krishna homoeopathic medical college |
Department of organon of medicine,Opd,Ipd,Rural health centres,Sarada krishna homoeopathic medical college,kulasekharam,Kanniyakumari,TamilNadu 629161
Kanniyakumari
TAMIL NADU |
7358779930
drkeerthu01@gmail.com |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| Institutional ethics committee sarada krishna homoeopathic medical college |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
(1) ICD-10 Condition: J459||Other and unspecified asthma, |
|
|
Intervention / Comparator Agent
|
| Type |
Name |
Details |
| Comparator Agent |
NOT APPLICABLE |
NOT APPLICABLE |
| Intervention |
SIMILIMUM BASED MEDICINE |
Case taking.The patient receives individualized medication every two weeks. Additionally, their progress is tracked and recorded using an assessment scale or questionnaire every three months. |
|
|
Inclusion Criteria
|
| Age From |
17.00 Year(s) |
| Age To |
80.00 Year(s) |
| Gender |
Both |
| Details |
Age group between 17 years to 80 years.
Both male and female.
Patient having symptoms of bronchial asthma such as dyspnoea, expiratory wheeze, cough and tightness of chest.
Patients with co – morbidities of bronchial asthma as mentioned earlier.
|
|
| ExclusionCriteria |
| Details |
Patient below 17 years and more than 80 years. Pregnant and lactating women.
Patients with complications of bronchial asthma such as pulmonary collapse, respiratory failure, pneumothorax, cor pulmonale and allergic bronchopulmonary aspergillosis.
|
|
|
Method of Generating Random Sequence
|
Not Applicable |
|
Method of Concealment
|
Not Applicable |
|
Blinding/Masking
|
Not Applicable |
|
Primary Outcome
|
| Outcome |
TimePoints |
| Reduction in the frequency and intensity of Bronchial asthma symptoms following individualized homoeopathic medicine |
Baseline, 3rd month and 6th month |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
| To know and produce improvement in associated co-morbid conditions |
baseline ,3rd month and 6th month |
|
|
Target Sample Size
|
Total Sample Size="34"
Sample Size from India="34"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
Phase 3/ Phase 4 |
|
Date of First Enrollment (India)
|
25/08/2025 |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="1"
Months="0"
Days="0" |
|
Recruitment Status of Trial (Global)
|
Not Yet Recruiting |
| Recruitment Status of Trial (India) |
Not Yet Recruiting |
|
Publication Details
|
N/A |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
|
Brief Summary
|
•Selection of 34 Bronchial asthma cases with at least one of their co morbidities. •Each patient’s characteristics (mental, emotional, and physical attributes) will be analyzed along with Bronchial asthma and its co - morbidity symptoms. •Totality of symptoms will be framed, emphasizing the individualization of the patient. •A suitable individualized remedy will be selected. •Pre-treatment assessment will be conducted using the AQLQ – Bronchial Asthma as well as for co – morbidities to establish a baseline symptom score. •And intervention will be done every two weeks. Additionally, their progress is tracked and recorded using an assessment scale or questionnaire every three months. •Post-treatment assessment will be conducted using the same assessment scale to evaluate changes in symptoms after treatment.
|